Offstream
news

Pfizer and its German partner BioNTech begin a clinical trial to test the safety and immune response of their Omicron-specific COVID-19 vaccine for adults under the age of 55 years.
2022-01-25

Health Canada approves the use of Pfizer's anti-COVID-19 viral drug Paxlovid for people over the age of 18 years who are at risk of severe disease and death.
2022-01-17

South Korea signs an agreement with Pfizer to purchase 30 million doses of the Pfizer–BioNTech COVID-19 vaccine in 2022 as part of a plan to administer 50 million "booster" doses of the vaccine.
2021-08-13

The U.S. Food and Drug Administration says that it has granted priority review for the vaccine developed by Pfizer and BioNTech. A decision on whether to fully approve the vaccine will likely be made within two months.
2021-07-16

Pfizer and BioNTech begin a clinical trial testing of their COVID-19 vaccine on healthy children between the ages of six months and 11 years, which is considered a crucial step towards vaccinating children.
2021-03-25

The government signs a deal with Pfizer and BioNTech to buy an additional 12.2 million doses of the tozinameran vaccine.
2021-01-11

Contrary to the strategy adopted by the United Kingdom, Spain is expected to maintain its plan to administer two doses per person of the COVID-19 vaccine tozinameran, which is the recommendation of the manufacturer Pfizer-BioNTech. Germany is also considering the single-dose strategy.
2021-01-4

The Czech Republic begins a vaccination campaign against COVID-19 using the Pfizer-BioNTech vaccine tozinameran, with Prime Minister Andrej Babiš and World War II veteran Emilie Řepíková among the first people to get vaccinated.
2020-12-27

The European Medicines Agency conditionally approves the vaccine made by Pfizer and BioNTech for use in European Union countries.
2020-12-21

Saudi Arabia begins its vaccination campaign a day after it received two shipments of the Pfizer-BioNTech vaccine. More than 150,000 people have registered to receive the vaccine.
2020-12-17